chr9-132897589-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2

The NM_000368.5(TSC1):​c.2647G>A​(p.Ala883Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000266 in 1,367,368 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A883V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00012 ( 0 hom., cov: 30)
Exomes 𝑓: 0.00028 ( 0 hom. )

Consequence

TSC1
NM_000368.5 missense

Scores

1
5
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7O:1

Conservation

PhyloP100: 3.35

Publications

9 publications found
Variant links:
Genes affected
TSC1 (HGNC:12362): (TSC complex subunit 1) This gene is a tumor suppressor gene that encodes the growth inhibitory protein hamartin. The encoded protein interacts with and stabilizes the GTPase activating protein tuberin. This hamartin-tuberin complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. This protein also functions as a co-chaperone for Hsp90 that inhibits its ATPase activity. This protein functions as a facilitator of Hsp90-mediated folding of kinase and non-kinase clients, including TSC2 and thereby preventing their ubiquitination and proteasomal degradation. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC1 Gene-Disease associations (from GenCC):
  • tuberous sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • tuberous sclerosis 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
  • lung lymphangioleiomyomatosis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • tuberous sclerosis complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.24118719).
BP6
Variant 9-132897589-C-T is Benign according to our data. Variant chr9-132897589-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 48985.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 15 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSC1NM_000368.5 linkc.2647G>A p.Ala883Thr missense_variant Exon 21 of 23 ENST00000298552.9 NP_000359.1 Q92574-1Q86WV8X5D9D2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSC1ENST00000298552.9 linkc.2647G>A p.Ala883Thr missense_variant Exon 21 of 23 1 NM_000368.5 ENSP00000298552.3 Q92574-1
TSC1ENST00000490179.4 linkc.2647G>A p.Ala883Thr missense_variant Exon 22 of 24 3 ENSP00000495533.2 A0A2R8Y6S8

Frequencies

GnomAD3 genomes
AF:
0.000117
AC:
15
AN:
128162
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.000199
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000127
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000584
AC:
13
AN:
222702
AF XY:
0.0000577
show subpopulations
Gnomad AFR exome
AF:
0.0000650
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000615
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000107
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000282
AC:
349
AN:
1239206
Hom.:
0
Cov.:
39
AF XY:
0.000253
AC XY:
156
AN XY:
617392
show subpopulations
African (AFR)
AF:
0.000142
AC:
4
AN:
28098
American (AMR)
AF:
0.00
AC:
0
AN:
35234
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19824
East Asian (EAS)
AF:
0.0000348
AC:
1
AN:
28742
South Asian (SAS)
AF:
0.00
AC:
0
AN:
75168
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
41070
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4440
European-Non Finnish (NFE)
AF:
0.000356
AC:
341
AN:
957898
Other (OTH)
AF:
0.0000616
AC:
3
AN:
48732
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.446
Heterozygous variant carriers
0
22
43
65
86
108
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000117
AC:
15
AN:
128162
Hom.:
0
Cov.:
30
AF XY:
0.0000833
AC XY:
5
AN XY:
60030
show subpopulations
African (AFR)
AF:
0.000199
AC:
7
AN:
35098
American (AMR)
AF:
0.00
AC:
0
AN:
10986
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3272
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3964
South Asian (SAS)
AF:
0.00
AC:
0
AN:
3600
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5480
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
242
European-Non Finnish (NFE)
AF:
0.000127
AC:
8
AN:
62930
Other (OTH)
AF:
0.00
AC:
0
AN:
1736
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000165
Hom.:
0
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.0000577
AC:
7

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Tuberous sclerosis 1 Benign:3
Apr 28, 2025
Myriad Genetics, Inc.
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Lymphangiomyomatosis;C1846385:Isolated focal cortical dysplasia type II;C1854465:Tuberous sclerosis 1 Benign:1
Mar 24, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Dec 09, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 22161988, 26494726) -

Hereditary cancer-predisposing syndrome Benign:1
May 30, 2023
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

TSC1-related disorder Benign:1
Nov 10, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Tuberous sclerosis syndrome Other:1
-
Tuberous sclerosis database (TSC1)
Significance:not provided
Review Status:no classification provided
Collection Method:curation

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Benign
-0.25
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.32
T;.;T;.;.;T;.;T;.;.;.
Eigen
Uncertain
0.27
Eigen_PC
Uncertain
0.38
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.86
.;D;D;D;D;.;.;.;D;D;.
M_CAP
Benign
0.055
D
MetaRNN
Benign
0.24
T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.34
T
MutationAssessor
Benign
0.76
N;.;N;.;.;N;.;N;.;.;.
PhyloP100
3.4
PrimateAI
Benign
0.46
T
PROVEAN
Benign
0.020
N;N;N;.;.;.;.;.;.;.;.
REVEL
Uncertain
0.33
Sift
Benign
0.080
T;D;T;.;.;.;.;.;.;.;.
Sift4G
Benign
0.072
T;T;T;.;.;.;.;.;.;.;.
Polyphen
0.80
P;.;P;.;.;P;.;P;.;.;.
Vest4
0.37
MVP
0.39
MPC
0.56
ClinPred
0.091
T
GERP RS
4.8
Varity_R
0.18
gMVP
0.066
Mutation Taster
=82/18
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs118203721; hg19: chr9-135772976; API